Tower Research Capital LLC (Trc) Dia Medica Therapeutics Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Dia Medica Therapeutics Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,118 shares of DMAC stock, worth $5,768. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,118

Previous 1,888 40.78%

Holding current value

$5,768

Previous $5,000 20.0%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$2.8 - $4.49 $2,156 - $3,457	-770 Reduced 40.78%	1,118 $4,000
Q2 2024 Aug 13, 2024	SELL	$2.16 - $3.66 $1,745 - $2,957	-808 Reduced 29.97%	1,888 $5,000
Q1 2024 May 15, 2024	SELL	$2.58 - $3.23 $11,785 - $14,754	-4,568 Reduced 62.89%	2,696 $7,000
Q4 2023 Feb 13, 2024	BUY	$2.05 - $2.99 $7,181 - $10,473	3,503 Added 93.14%	7,264 $20,000
Q3 2023 Nov 14, 2023	SELL	$2.56 - $4.4 $6,346 - $10,907	-2,479 Reduced 39.73%	3,761 $9,000
Q2 2023 Aug 14, 2023	BUY	$1.53 - $4.4 $388 - $1,117	254 Added 4.24%	6,240 $26,000
Q1 2023 May 09, 2023	BUY	$1.32 - $1.89 $3,038 - $4,350	2,302 Added 62.49%	5,986 $9,000
Q4 2022 Feb 10, 2023	BUY	$1.13 - $1.62 $3,057 - $4,383	2,706 Added 276.69%	3,684 $6,000
Q3 2022 Nov 10, 2022	SELL	$1.2 - $2.07 $2,150 - $3,709	-1,792 Reduced 64.69%	978 $1,000
Q2 2022 Aug 15, 2022	BUY	$1.86 - $2.62 $2,049 - $2,887	1,102 Added 66.07%	2,770 $6,000
Q1 2022 May 12, 2022	SELL	$2.29 - $3.88 $17,614 - $29,844	-7,692 Reduced 82.18%	1,668 $5,000
Q4 2021 Feb 14, 2022	BUY	$3.43 - $4.65 $27,062 - $36,688	7,890 Added 536.73%	9,360 $35,000
Q3 2021 Nov 15, 2021	SELL	$3.1 - $4.32 $10,784 - $15,029	-3,479 Reduced 70.3%	1,470 $6,000
Q2 2021 Aug 16, 2021	BUY	$4.45 - $9.91 $17,973 - $40,026	4,039 Added 443.85%	4,949 $22,000
Q1 2021 May 17, 2021	BUY	$7.76 - $10.43 $7,061 - $9,491	910 New	910 $8,000
Q4 2020 Feb 16, 2021	SELL	$4.13 - $10.14 $5,711 - $14,023	-1,383 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$3.91 - $7.15 $5,407 - $9,888	1,383 New	1,383 $6,000
Q2 2019 Aug 13, 2019	SELL	$2.7 - $4.96 $191 - $352	-71 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$3.1 - $4.54 $220 - $322	71 New	71 $0

Others Institutions Holding DMAC

# of Institutions

Shares Held

4.22M

Call Options Held

8.2K

Put Options Held

200

View Full List

About DiaMedica Therapeutics Inc.

Ticker DMAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,443,100
Market Cap $136M
Description
DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX trial for the treatment of patients with moderate or severe chronic kidney disease caused by Type...

More about DMAC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Dia Medica Therapeutics Inc. Transaction History